Tanner Pharma Group Announces New Managing Director Of UK Operation

CHARLOTTE, N.C.--(BUSINESS WIRE)--Tanner Pharma Group is pleased to announce the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.

Mr. Bracey brings two decades of management experience, making him an optimal candidate in leading the recently established UK/EU operations based in London. Prior to joining Tanner Pharma Group, Mr. Bracey led various operations in Big Pharma, Specialty Pharma, Generics and most recently consultancy within the pharmaceutical industry. Within these organizations, he worked in general management, operations, sales, procurement, and supply chain roles with UK, EU, MENA, and Global reach. Mr. Bracey also served in HMS as a logistics officer.

Sponsored by GenScript

Accelerate Biologics, Gene and Cell Therapy Product Development partnering with GenScript ProBio

GenScript ProBio is the bio-pharmaceutical CDMO segment of the world’s leading biotech company GenScript, proactively providing end-to-end service from drug discovery to commercialization with professional solutions and efficient processes to accelerate drug development for customers.

Suggested Articles

While the biotech IPO market booms, it can look like going public is easy. But the right strategy, syndicate and aftermarket are still important.

Gene therapy pioneer Jim Wilson and the University of Pennsylvania are teaming up with Regeneron to help deliver its COVID antibody intransally.

Forty percent of PK deficiency patients on mitapivat had hemoglobalin responses, compared to 0% in the placebo group.